Drug Trial Radar · NCT07140783
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
580
Planned (sponsor's estimate)
Start
Sep 2, 2025
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Opus Genetics, IncIndustry
- Sponsor type
- Industry
- First posted
- Aug 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if Phentolamine Ophthalmic Solution works to treat adults that have had keratorefractive surgery and have decreased visual acuity under mesopic conditions. It will also learn about the safety of Phentolamine Ophthalmic Solution. The main questions it aims to answer are: Researchers will compare Phentolamine Ophthalmic Solution to a placebo (a look-alike substance that contains no drug) to see if Phentolamine Ophthalmic Solution works to improve vision in low light conditions. Participants will: Take Phentolamine Ophthalmic Solution or a placebo drop every day for 2 weeks Visit the clinic once every week for 2 weeks for checkups and tests Keep a diary of when they instill the study medication each evening
Conditions
- Vision Loss Night
- Vision Disorders
Interventions
0.75% Phentolamine Ophthalmic SolutionDrug
Once daily dosing
PlaceboDrug
Once daily dosing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of participants with >= 15 ETDRS letters (>= 3 lines) improvement in the study eye in mLCVA compared to Baseline (Day1 pre-dose) at Day 15Time frame: Day 15
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Arizona Eye Care
Chandler, Arizona · Recruiting
Eye Doctors of Arizona
Phoenix, Arizona · Recruiting
MRB Eye Care Consultants
Scottsdale, Arizona · Recruiting
Global Research Management
Glendale, California · Recruiting
Gordon Schanzlin New Vision
La Jolla, California · Recruiting
Eye Research Foundation
Newport Beach, California · Recruiting
California Eye Specialists Medical Group
Pasadena, California · Recruiting
NVISION Clinical Research
San Diego, California · Recruiting
Scripps Poway Eyecare and Optometry
San Diego, California · Recruiting
Wolsten and Goldberg Eye Assoc.
Torrance, California · Recruiting
Segal Drug Trials
Delray Beach, Florida · Recruiting
Wyse Eyecare
Northbrook, Illinois · Recruiting
Virdi Eye Clinic
Rock Island, Illinois · Recruiting
Kannarr Eye Care
Pittsburg, Kansas · Recruiting
Northeast Eye Research Associates
Woburn, Massachusetts · Recruiting
Oculus Research
Garner, North Carolina · Recruiting
Scott & Christie EyeCare Associates
Cranberry Township, Pennsylvania · Recruiting
West Bay Eye Assoc.
Warwick, Rhode Island · Recruiting
Zillan Clinical Research
Houston, Texas · Recruiting
Hoopes Vision
Draper, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.